News

Belgium halved its trial approval times, now the delays come after approval [Partner Content]

Rapporteur

The medicines agency says Belgium is 'the fastest in Europe' for trials run only in Belgium, but a ten-year review of the public trials programme found that signing contracts can still take months

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.